Short Interest in Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Grows By 17.9%

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) saw a large increase in short interest in January. As of January 31st, there was short interest totalling 689,100 shares, an increase of 17.9% from the January 15th total of 584,300 shares. Currently, 2.1% of the shares of the stock are short sold. Based on an average daily volume of 225,300 shares, the short-interest ratio is presently 3.1 days.

Bioceres Crop Solutions Trading Up 4.6 %

NASDAQ:BIOX traded up $0.22 during mid-day trading on Friday, hitting $4.96. 946,893 shares of the company’s stock were exchanged, compared to its average volume of 217,854. The company has a 50 day simple moving average of $6.46 and a 200-day simple moving average of $7.62. The company has a current ratio of 1.27, a quick ratio of 0.87 and a debt-to-equity ratio of 0.37. Bioceres Crop Solutions has a fifty-two week low of $4.42 and a fifty-two week high of $13.64. The firm has a market capitalization of $311.04 million, a P/E ratio of 248.12 and a beta of 0.57.

Analyst Upgrades and Downgrades

BIOX has been the topic of a number of research analyst reports. Oppenheimer reduced their price target on shares of Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating on the stock in a research note on Tuesday, January 28th. Lake Street Capital reduced their price target on shares of Bioceres Crop Solutions from $13.00 to $8.00 and set a “buy” rating on the stock in a research note on Friday, February 7th. Finally, Canaccord Genuity Group reduced their price target on shares of Bioceres Crop Solutions from $7.00 to $6.50 and set a “buy” rating on the stock in a research note on Thursday. Four equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $9.88.

Institutional Investors Weigh In On Bioceres Crop Solutions

Several hedge funds have recently added to or reduced their stakes in BIOX. Jump Financial LLC acquired a new stake in Bioceres Crop Solutions during the 4th quarter worth approximately $72,000. Northern Trust Corp acquired a new stake in Bioceres Crop Solutions during the 4th quarter worth approximately $93,000. Ping Capital Management Inc. boosted its position in Bioceres Crop Solutions by 7.3% during the 4th quarter. Ping Capital Management Inc. now owns 44,000 shares of the company’s stock worth $268,000 after buying an additional 3,000 shares during the period. Stifel Financial Corp raised its holdings in Bioceres Crop Solutions by 33.4% during the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock worth $321,000 after purchasing an additional 10,224 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its holdings in Bioceres Crop Solutions by 17.0% during the 4th quarter. JPMorgan Chase & Co. now owns 105,301 shares of the company’s stock worth $640,000 after purchasing an additional 15,328 shares during the last quarter. 17.68% of the stock is currently owned by institutional investors and hedge funds.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.